Cargando…
Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725978/ https://www.ncbi.nlm.nih.gov/pubmed/36473119 http://dx.doi.org/10.18632/oncotarget.28320 |
| _version_ | 1784844682734338048 |
|---|---|
| author | Chen, Yongshun Wu, Xiaoyuan Hao, Daxuan Cheng, Xinyu Zhang, Lei Zhang, Yougai Ke, Shaobo Shi, Wei He, Chunyu |
| author_facet | Chen, Yongshun Wu, Xiaoyuan Hao, Daxuan Cheng, Xinyu Zhang, Lei Zhang, Yougai Ke, Shaobo Shi, Wei He, Chunyu |
| author_sort | Chen, Yongshun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9725978 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97259782022-12-08 Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma Chen, Yongshun Wu, Xiaoyuan Hao, Daxuan Cheng, Xinyu Zhang, Lei Zhang, Yougai Ke, Shaobo Shi, Wei He, Chunyu Oncotarget Addendum Impact Journals LLC 2022-12-06 /pmc/articles/PMC9725978/ /pubmed/36473119 http://dx.doi.org/10.18632/oncotarget.28320 Text en Copyright: © 2022 Chen et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Addendum Chen, Yongshun Wu, Xiaoyuan Hao, Daxuan Cheng, Xinyu Zhang, Lei Zhang, Yougai Ke, Shaobo Shi, Wei He, Chunyu Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
| title | Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
| title_full | Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
| title_fullStr | Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
| title_full_unstemmed | Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
| title_short | Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
| title_sort | addendum: neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
| topic | Addendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725978/ https://www.ncbi.nlm.nih.gov/pubmed/36473119 http://dx.doi.org/10.18632/oncotarget.28320 |
| work_keys_str_mv | AT chenyongshun addendumneoadjuvantnimotuzumabpluschemoradiotherapycomparedtoneoadjuvantchemoradiotherapyandneoadjuvantchemotherapyforlocallyadvancedesophagealsquamouscellcarcinoma AT wuxiaoyuan addendumneoadjuvantnimotuzumabpluschemoradiotherapycomparedtoneoadjuvantchemoradiotherapyandneoadjuvantchemotherapyforlocallyadvancedesophagealsquamouscellcarcinoma AT haodaxuan addendumneoadjuvantnimotuzumabpluschemoradiotherapycomparedtoneoadjuvantchemoradiotherapyandneoadjuvantchemotherapyforlocallyadvancedesophagealsquamouscellcarcinoma AT chengxinyu addendumneoadjuvantnimotuzumabpluschemoradiotherapycomparedtoneoadjuvantchemoradiotherapyandneoadjuvantchemotherapyforlocallyadvancedesophagealsquamouscellcarcinoma AT zhanglei addendumneoadjuvantnimotuzumabpluschemoradiotherapycomparedtoneoadjuvantchemoradiotherapyandneoadjuvantchemotherapyforlocallyadvancedesophagealsquamouscellcarcinoma AT zhangyougai addendumneoadjuvantnimotuzumabpluschemoradiotherapycomparedtoneoadjuvantchemoradiotherapyandneoadjuvantchemotherapyforlocallyadvancedesophagealsquamouscellcarcinoma AT keshaobo addendumneoadjuvantnimotuzumabpluschemoradiotherapycomparedtoneoadjuvantchemoradiotherapyandneoadjuvantchemotherapyforlocallyadvancedesophagealsquamouscellcarcinoma AT shiwei addendumneoadjuvantnimotuzumabpluschemoradiotherapycomparedtoneoadjuvantchemoradiotherapyandneoadjuvantchemotherapyforlocallyadvancedesophagealsquamouscellcarcinoma AT hechunyu addendumneoadjuvantnimotuzumabpluschemoradiotherapycomparedtoneoadjuvantchemoradiotherapyandneoadjuvantchemotherapyforlocallyadvancedesophagealsquamouscellcarcinoma |